公司概覽
業務類別 Biotechnology
業務概覽 CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designedto take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
公司地址 151 Oyster Point Boulevard, Suite 400, South San Francisco, CA, USA, 94080
電話號碼 +1 650 515-3185
傳真號碼 +1 650 351-0353
公司網頁 https://www.cytomx.com
員工數量 69
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Sean A. McCarthy, D.Phil. Chief Executive Officer and Chairman of the Board 美元 675.29K 30/04/2026
Mr. Yu-Waye Wayne Chu Senior Vice President and Chief Medical Officer -- 30/04/2026
Mr. Christopher W. Ogden Senior Vice President, Chief Financial Officer and Principal Accounting Officer -- 30/04/2026
Dr. Marcia P. Belvin, PhD Senior Vice President and Chief Scientific Officer -- 30/04/2026
Ms. Rachael Lester Senior Vice President and Chief Business Officer 美元 77.02K 30/04/2026
 
董事會成員
董事會 職務 更新日期
Mr. James R. Meyers Independent Director 30/04/2026
Dr. Elaine V. Jones, PhD Independent Director 30/04/2026
Ms. Halley E. Gilbert Independent Director 30/04/2026
Mr. Matthew P. Young Lead Independent Director 30/04/2026
Dr. Sean A. McCarthy, D.Phil. Chief Executive Officer and Chairman of the Board 30/04/2026
Dr. Mani Mohindru, PhD Independent Director 30/04/2026
Mr. Charles S. Fuchs Director 27/07/2026
Dr. Alan Ashworth, F.R.S.,PhD Independent Director 30/04/2026
Dr. Zhen Su, M.D. Independent Director 30/04/2026
 
所屬ETF (更新日期: 14/11/2026 04:20)
代號 名稱 佔比% ▼ 持有日期
BBCVirtus Biotech Clinical Trials ETF0.04%30/10/2026
VTWVVanguard Russell 2000 Value ETF0.04%30/09/2026
DFACDimensional US Core Equity 2 ETF0.03%02/10/2026
EESWisdomTree US SmallCap Earnings ETF0.03%30/10/2026
AVSCAvantis US Small Cap Equity ETF0.03%30/10/2026
IWViShares Russell 3000 ETF0.03%30/10/2026
ISCViShares Morningstar Small-Cap Value ETF0.02%30/10/2026
QQQSInvesco NASDAQ Future Gen 200 ETF0.02%30/10/2026
DFAUDimensional US Core Equity Market ETF0.01%30/10/2026
TILTNorthern Trust Mstar US Mkt Fac Tlt ETF0.01%30/10/2026
TECBiShares US Tech Breakthrough Mltsctr ETF0.01%30/10/2026
IBBQInvesco Nasdaq Biotechnology ETF0.01%30/10/2026
VTHRVanguard Russell 3000 ETF0.01%30/09/2026
SPGMState Street® SPDR® Ptf MSCIGlbStkMktETF0.01%30/10/2026
DCORDimensional US Core Equity 1 ETF0.01%24/09/2026
ITWOProShares Russell 2000 High Income ETF0.005%30/10/2026
MSSMMorgan Stanley Pathway Sm-Md Cp Eq ETF0.004%31/10/2026
BIBProShares Ultra Nasdaq Biotechnology0.004%30/10/2026
URTYProShares UltraPro Russell20000.004%30/10/2026
MSMLiShares MSCI USA Small-Cap ETF0.003%30/10/2026
  1   2    3  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.